Order Article Reprints

Mansour A, Mahmoud MY, Bakr AF, Ghoniem MG, Adam FA, El-Sherbiny IM. Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. Pharmaceutics 2022, 14, 2668. Pharmaceutics. 2023; 15(3):994. https://doi.org/10.3390/pharmaceutics15030994

Mansour, Amira, Mohamed Y. Mahmoud, Alaa F. Bakr, Monira G. Ghoniem, Fatima A. Adam, and Ibrahim M. El-Sherbiny. 2023. "Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. Pharmaceutics 2022, 14, 2668" Pharmaceutics 15, no. 3: 994. https://doi.org/10.3390/pharmaceutics15030994

Mansour, A., Mahmoud, M. Y., Bakr, A. F., Ghoniem, M. G., Adam, F. A., & El-Sherbiny, I. M. (2023). Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. Pharmaceutics 2022, 14, 2668. Pharmaceutics, 15(3), 994. https://doi.org/10.3390/pharmaceutics15030994